Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Iguratimod in Hand Osteoarthritis
NCT05216757Phase 3Unknown
- Sponsor
- Peking University People's Hospital
- Start
- Mar 2022
- Primary completion
- Dec 2024
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of iguratimod in hand osteoarthritis, inflammatory arthritis, sponsored by Peking University People's Hospital. Status: unknown.
02
Drugs
iguratimod
03
Conditions
hand osteoarthritisinflammatory arthritis
Beyond the preview
Go deeper on NCT05216757.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05216757.